Joanne A. Hammill

712 total citations
18 papers, 493 citations indexed

About

Joanne A. Hammill is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Joanne A. Hammill has authored 18 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Joanne A. Hammill's work include CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (4 papers). Joanne A. Hammill is often cited by papers focused on CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (4 papers). Joanne A. Hammill collaborates with scholars based in Canada, Poland and United States. Joanne A. Hammill's co-authors include Jonathan L. Bramson, Daniela Tantalo, Galina Denisova, Christopher W. Helsen, Jacek M. Kwiecień, Jennifer Bassett, Carole Evelegh, Sophie M. Poznanski, Yonghong Wan and Ali A. Ashkar and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Joanne A. Hammill

17 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanne A. Hammill Canada 10 387 254 117 109 105 18 493
Erica M. Gomes United States 7 379 1.0× 204 0.8× 144 1.2× 148 1.4× 100 1.0× 12 485
Anthony Leonardi United States 6 377 1.0× 292 1.1× 139 1.2× 108 1.0× 72 0.7× 10 518
Justin C. Boucher United States 12 398 1.0× 254 1.0× 162 1.4× 131 1.2× 116 1.1× 31 571
Degui Geng United States 9 308 0.8× 321 1.3× 139 1.2× 84 0.8× 130 1.2× 14 565
Trisha R. Berger United States 9 373 1.0× 175 0.7× 147 1.3× 102 0.9× 133 1.3× 20 469
Xueqiang Zhao China 10 500 1.3× 299 1.2× 189 1.6× 123 1.1× 171 1.6× 14 667
Vania Baldan United Kingdom 6 294 0.8× 144 0.6× 109 0.9× 72 0.7× 83 0.8× 9 360
Daniel Garafola United States 6 262 0.7× 237 0.9× 149 1.3× 57 0.5× 115 1.1× 6 412
Brook Jeang United States 5 505 1.3× 175 0.7× 158 1.4× 201 1.8× 192 1.8× 9 593
Theresa Kaeuferle Germany 9 393 1.0× 165 0.6× 207 1.8× 126 1.2× 92 0.9× 15 518

Countries citing papers authored by Joanne A. Hammill

Since Specialization
Citations

This map shows the geographic impact of Joanne A. Hammill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne A. Hammill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne A. Hammill more than expected).

Fields of papers citing papers by Joanne A. Hammill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne A. Hammill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne A. Hammill. The network helps show where Joanne A. Hammill may publish in the future.

Co-authorship network of co-authors of Joanne A. Hammill

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne A. Hammill. A scholar is included among the top collaborators of Joanne A. Hammill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne A. Hammill. Joanne A. Hammill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cummings, Derek T., Bojana Bojović, Chitra Venugopal, et al.. (2025). DAP12-associated synthetic antigen receptors enable multi-targeting of T cells with independent chimeric receptors in a small genetic payload. iScience. 28(4). 112142–112142.
2.
McNicol, Jamie, Stephen M. Collins, Joanne A. Hammill, et al.. (2025). Humanized mouse models of KRAS -mutated colorectal and pancreatic cancers with HLA-class-I match for pre-clinical evaluation of cancer immunotherapies. OncoImmunology. 14(1). 2473163–2473163. 2 indexed citations
3.
Denisova, Galina, et al.. (2024). Electrophilic proximity-inducing synthetic adapters enhance universal T cell function by covalently enforcing immune receptor signaling. SHILAP Revista de lepidopterología. 32(3). 200842–200842. 5 indexed citations
4.
Hammill, Joanne A., Derek T. Cummings, Bojana Bojović, et al.. (2023). T-cell engineered with a fully humanized B-cell maturation antigen-specific T-cell antigen coupler receptor effectively target multiple myeloma. Cytotherapy. 25(5). 490–501. 2 indexed citations
5.
Portillo, Ana L., Richard T. Hogg, Sophie M. Poznanski, et al.. (2021). Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors. iScience. 24(6). 102619–102619. 51 indexed citations
6.
Lau, Vivian Wing Chong, Bojana Bojović, Gregory R. Steinberg, et al.. (2021). Manufacturing T cells in hollow fiber membrane bioreactors changes their programming and enhances their potency. OncoImmunology. 10(1). 1995168–1995168. 3 indexed citations
7.
Hammill, Joanne A., Jacek M. Kwiecień, Anna Dvorkin‐Gheva, et al.. (2020). A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity. Molecular Therapy — Oncolytics. 17. 278–292. 12 indexed citations
8.
Helsen, Christopher W., et al.. (2019). Development of a CD19-TAC therapy in preparation of human trials. Cytotherapy. 21(5). S26–S26. 2 indexed citations
9.
Poznanski, Sophie M., Tina Nham, Marianne V. Chew, et al.. (2018). Expanded CD56superbrightCD16+ NK Cells from Ovarian Cancer Patients Are Cytotoxic against Autologous Tumor in a Patient-Derived Xenograft Murine Model. Cancer Immunology Research. 6(10). 1174–1185. 43 indexed citations
10.
Helsen, Christopher W., Joanne A. Hammill, Vivian Wing Chong Lau, et al.. (2018). The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity. Nature Communications. 9(1). 3049–3049. 106 indexed citations
11.
Helsen, Christopher W., et al.. (2018). T Cells Engineered with T Cell Antigen Coupler (TAC) Receptors for Haematological Malignancies. Blood. 132(Supplement 1). 3267–3267. 2 indexed citations
12.
Lai, Rocky, Mangalakumari Jeyanathan, Sam Afkhami, et al.. (2018). CD11b+ Dendritic Cell–Mediated Anti–Mycobacterium tuberculosis Th1 Activation Is Counterregulated by CD103+ Dendritic Cells via IL-10. The Journal of Immunology. 200(5). 1746–1760. 25 indexed citations
13.
Houde, Vanessa P., Sara Donzelli, Andrea Sacconi, et al.. (2017). AMPK β1 reduces tumor progression and improves survival in p53 null mice. Molecular Oncology. 11(9). 1143–1155. 32 indexed citations
14.
Hammill, Joanne A., et al.. (2016). Viral Engineering of Chimeric Antigen Receptor Expression on Murine and Human T Lymphocytes. Methods in molecular biology. 1458. 137–157. 9 indexed citations
15.
Tantalo, Daniela, et al.. (2015). Chimeric antigen receptor–engineered T cells as oncolytic virus carriers. Molecular Therapy — Oncolytics. 2. 15014–15014. 59 indexed citations
16.
Hammill, Joanne A., Anna Dvorkin‐Gheva, Daniela Tantalo, et al.. (2015). T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice. Molecular Therapy. 23(10). 1600–1610. 65 indexed citations
17.
Hammill, Joanne A., Christopher W. Helsen, Galina Denisova, et al.. (2015). Designed ankyrin repeat proteins are effective targeting elements for chimeric antigen receptors. Journal for ImmunoTherapy of Cancer. 3(1). 55–55. 66 indexed citations
18.
Bassett, Jennifer, Stephanie L. Swift, Joanne A. Hammill, et al.. (2011). Combined mTOR Inhibition and OX40 Agonism Enhances CD8+ T Cell Memory and Protective Immunity Produced by Recombinant Adenovirus Vaccines. Molecular Therapy. 20(4). 860–869. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erica M. Gomes Breakdown of academic impact, for papers by Anthony Leonardi Breakdown of academic impact, for papers by Justin C. Boucher Breakdown of academic impact, for papers by Degui Geng Breakdown of academic impact, for papers by Trisha R. Berger Breakdown of academic impact, for papers by Xueqiang Zhao Breakdown of academic impact, for papers by Vania Baldan Breakdown of academic impact, for papers by Daniel Garafola Breakdown of academic impact, for papers by Brook Jeang Breakdown of academic impact, for papers by Theresa Kaeuferle
Rankless by CCL
2026